The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 2, 2010, Pages 920-927

  Virdis, Agostino ^a   Cetani, Filomena ^a   Giannarelli, Chiara ^a   Banti, Chiara ^a   Ghiadoni, Lorenzo ^a   Ambrogini, Elena ^a   Carrara, Davide ^a   Pinchera, Aldo ^a   Taddei, Stefano ^a   Bernini, Giampaolo ^a   Marcocci, Claudio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ASCORBIC ACID; CYTOCHROME P450 2C9; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; SULFAPHENAZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FOREARM BLOOD FLOW; HUMAN; OXIDATIVE STRESS; PARATHYROIDECTOMY; PLETHYSMOGRAPHY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 76149134322     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1669     Document Type: Article

References (25)

1. Lerman A, Zeiher AM 2005 Endothelial function: cardiac events. Circulation 111:363-368
2. Taddei S, Ghiadoni L, Virdis A, Buralli S, Salvetti A 1999 Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Circulation 100:1400-1405
3. Taddei S, Versari D, Cipriano A, Ghiadoni L, Galetta F, Franzoni F, Magagna A, Virdis A, Salvetti A 2006 Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol 48:508-515
4. Giannarelli C, Virdis A, De Negri F, Magagna A, Duranti E, Salvetti A, Taddei S 2009 Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients. Circulation 119:1625-1633
5. Andersson P, Rydberg E, Willenheimer R 2004 Primary hyperparathyroidism and heart disease-a review. Eur Heart J 25:1776-1787
6. Ybarra J, Doñate T, Jurado J, Pou JM 2007 Primary hyperparathyroidism, insulin resistance, and cardiovascular disease: a review. Nurs Clin North Am 42:79-85, vii
7. Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J 2009 Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119:2765-2771
8. Jiang B, Morimoto S, Yang J, Niinoabu T, Fukuo K, Ogihara T 1998 Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells. J Cardiovasc Pharmacol 31(Suppl 1):S142-S144
9. Kosch M, Hausberg M, Vormbrock K, Kisters K, Gabriels G, Rahn KH, Barenbrock M 2000 Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 47:813-818
10. Baykan M, Erem C, ErdoCrossed d signan T, HacihasanoCrossed d signlu A, Gedikli O, Kirip A, KüçükosmanoCrossed d signlu M, Ersöz HO, Celik S 2007 Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int J Cardiovasc Imaging 23:323-328
11. Nilsson IL, Aberg J, Rastad J, Lind L 1999 Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 126:1049-1055
12. Neunteufl T, Katzenschlager R, Abela C, Kostner K, Niederle B, Weidinger F, Stefenelli T 1998 Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 40:396-401
13. Neunteufl T, Heher S, Prager G, Katzenschlager R, Abela C, Niederle B, Stefenelli T 2000 Effects of successful parathyroidectomy on altered arterial reactivity in patients with hypercalcaemia: results of a 3-year follow-up study. Clin Endocrinol (Oxf) 53:229-233
14. Virdis A, Ghiadoni L, Cardinal H, Favilla S, Duranti P, Birindelli R, Magagna A, Bernini G, Salvetti G, Taddei S, Salvetti A 2001 Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol 38:1106-1115
15. Taddei S, Ghiadoni L, Virdis A, Versari D, Salvetti A 2003 Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategies. Curr Pharm Des 9:2385-2402
16. Fleming I 2004 Cytochrome P450 epoxygenases as EDHF synthase(s). Pharmacol Res 49:525-533
17. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, Kiowski W, Lüscher TF, Mancia G, Natali A, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Spieker LE, Taddei S, Webb DJ 2005 Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 23:233-246
18. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A 1998 Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97:2222-2229
19. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A 2001 Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38:274-279
20. Leong T, Zylberstein D, Graham I, Lissner L, Ward D, Fogarty J, Bengtsson C, Björkelund C, Thelle D 2008 Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg. Arterioscler Thromb Vasc Biol 28: 961-967
21. Isales CM, Sumpio B, Bollag RJ, Zhong Q, Ding KH, Du W, Rodriguez-Commes J, Lopez R, Rosales OR, Gasalla-Herraiz J, McCarthy R, Barrett PQ 2000 Functional parathyroid hormone receptors are present in an umbilical vein endothelial cell line.AmJ Physiol Endocrinol Metab 279:E654-E662
22. Kalinowski L, Dobrucki LW, Malinski T 2001 Nitric oxide as a second messenger in parathyroid hormone-related protein signaling. J Endocrinol 170:433-440
23. Nickols GA, Metz MA, Cline Jr WH 1986 Endothelium-independent linkage of parathyroid hormone receptors of rat vascular tissue with increased adenosine 3′,5′-monophosphate and relaxation of vascular smooth muscle. Endocrinology 119:349-356
24. Fleming I, Busse R 2003 Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284:R1-R12
25. Ghiadoni L, Versari D, Magagna A, Kardasz I, Plantinga Y, Giannarelli C, Taddei S, Salvetti A 2007 Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens 25:361-366